Arca Biopharma | ABIO - Pasivo Circulante





Pasivo Circulante Cambio Fecha
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
Amgen USD 24.96B 534M 2026-03
Arca Biopharma USD 16.63M 1.26M 2026-03
Biogen USD 3B 350.5M 2026-03
Brainstorm Cell Therapeutics USD 11.76M 757K 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Capricor Therapeutics USD 33.64M 2.2M 2026-03
Cipla INR 70.14B 7.16B 2026-03
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.04M 533K 2026-03
CSL USD 4.61B 207M 2025-12
Cytokinetics USD 199.18M 3.27M 2026-03
Daiichi Sankyo JPY 778.55B 77.51B 2025-12
Gilead Sciences USD 9.48B 2.34B 2026-03
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
Grifols EUR 2.37B 156.97M 2025-12
Laboratory Of America USD 2.64B 182.5M 2026-03
Myriad Genetics USD 130.2M 3.6M 2026-03
Otsuka Holdings JPY 686.12B 63B 2026-03
Pfizer USD 34.35B 2.64B 2026-03
United Therapeutics USD 599.1M 38.5M 2026-03